Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease

Autologous hematopoietic stem cells transplantation (AHSCT) has been employed as treatment for severe systemic sclerosis (SSc) with high risk of organ failure. In the last 25 years overall survival and treatment-related mortality have improved, in accordance with a better patient selection and mobil...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagnato, Gianluca, Versace, Antonio Giovanni, La Rosa, Daniela, De Gaetano, Alberta, Imbalzano, Egidio, Chiappalone, Marianna, Ioppolo, Carmelo, Roberts, William Neal, Bitto, Alessandra, Irrera, Natasha, Allegra, Alessandro, Pioggia, Giovanni, Gangemi, Sebastiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909673/
https://www.ncbi.nlm.nih.gov/pubmed/35269465
http://dx.doi.org/10.3390/cells11050843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909673/
https://www.ncbi.nlm.nih.gov/pubmed/35269465
http://dx.doi.org/10.3390/cells11050843

Ejemplares similares